David Paul Schenkein
David Paul Schenkein occupies the position of General Partner for GV Management Co. LLC. He is also on the board of 6 other companies.
In the past Dr. Schenkein was Venture Partner at ARCH Venture Partners LLC, Senior Vice President-Oncology Development at Genentech, Inc., Senior Vice President-Clinical Research at Millennium Pharmaceuticals, Inc. and Associate Professor at Tufts Medical Center, Inc.
He received an undergraduate degree from Wesleyan University and a doctorate from SUNY Upstate Medical University.
Transactions
Date
Transaction
Value
| 06/02/2022 | 5,986 | Award at $0 per share. | 0 |
| 06/02/2021 | 2,074 | Award at $0 per share. | 0 |
| 06/01/2021 | 3,253 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 12/21/2020 | 5,000 | Disposition at $90.01 per share. | 450,050 |
| 12/21/2020 | 25,000 | Disposition at $90.06 per share. | 2,251,500 |
| 11/12/2020 | 30,000 | Disposition at $70.05 per share. | 2,101,500 |
| 11/10/2020 | 10,000 | Disposition at $60.03 per share. | 600,300 |
| 11/04/2020 | 10,000 | Disposition at $50.18 per share. | 501,800 |
